Moreover, we did not observe transcriptional upregulation of any established checkpoint markers (PD-1, TIGIT, CTLA-4, TIM-3, LAG-3, etc.)in tumor NK cells, though this could be a function of measuring active RNA transcriptional differences by RNA sequencing as opposed to protein expression by other laboratory techniques. The gene discussed is HAVCR2; the disease is neoplasm.